182 related articles for article (PubMed ID: 1741165)
1. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
[TBL] [Abstract][Full Text] [Related]
2. Reversion of human prostate tumorigenic growth by azatyrosine.
Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
[TBL] [Abstract][Full Text] [Related]
3. Azatyrosine inhibits neurite outgrowth of PC12 cells induced by oncogenic Ras.
Fujita-Yoshigaki J; Yokoyama S; Shindo-Okada N; Nishimura S
Oncogene; 1992 Oct; 7(10):2019-24. PubMed ID: 1328988
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
[TBL] [Abstract][Full Text] [Related]
5. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
Lebeau J; Le Chalony C; Prosperi MT; Goubin G
Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
[TBL] [Abstract][Full Text] [Related]
6. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
8. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.
Sato KY; Polakis PG; Haubruck H; Fasching CL; McCormick F; Stanbridge EJ
Cancer Res; 1994 Jan; 54(2):552-9. PubMed ID: 8275494
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
Yokoyama T
Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
[TBL] [Abstract][Full Text] [Related]
11. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
12. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
13. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
14. Permanent conversion of mouse and human cells transformed by activated ras or raf genes to apparently normal cells by treatment with the antibiotic azatyrosine.
Shindo-Okada N; Makabe O; Nagahara H; Nishimura S
Mol Carcinog; 1989; 2(3):159-67. PubMed ID: 2675904
[TBL] [Abstract][Full Text] [Related]
15. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.
Krzyzosiak WJ; Shindo-Okada N; Teshima H; Nakajima K; Nishimura S
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4879-83. PubMed ID: 1594588
[TBL] [Abstract][Full Text] [Related]
16. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
Jelinek MA; Hassell JA
Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
[TBL] [Abstract][Full Text] [Related]
17. The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependent.
Redmond SM; Reichmann E; Müller RG; Friis RR; Groner B; Hynes NE
Oncogene; 1988 Mar; 2(3):259-65. PubMed ID: 3127778
[TBL] [Abstract][Full Text] [Related]
18. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
19. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action of azatyrosine: recent process].
Monden Y; Shindo-Okada N; Nishimura S
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1563-70. PubMed ID: 9309155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
